Image of the paper-based isotachophoresis (ITP) device that isolates, enriches, and detects exosomes from a prostate cancer cell line.
Washington State University researchers have developed a technology that is more than 30 times more sensitive than current lab-based tests in finding early stage cancer biomarkers in blood.
The technology uses an electric field to concentrate and separate cancer biomarkers onto a paper strip. It could someday become a kind of liquid biopsy and could lead to earlier detection of and faster treatments for cancer, a disease that causes more than 9.6 million deaths a year around the world.
Led by Wenji Dong, associate professor in the Gene and Linda Voiland School of Chemical Engineering and Bioengineering, and graduate student Shuang Guo, the researchers were able to detect miniscule levels of the cancer markers in tiny extracellular bubbles called exosomes in as little as 10 minutes. Reporting on their work in the journal, Biosensors and Bioelectronics, the researchers call the work a “significant step” in developing rapid testing and early cancer detection.
Researchers have long sought ways to detect cancer earlier to save more lives. While lab tests to detect tumor biomarkers in blood have been developed, they often can’t find early-stage cancer because the cancer markers are at levels too low to detect. Instead, people most often find out they have cancer through invasive biopsies once tumors are established.In recent years, researchers have discovered that one of the ways cancer cells spread and communicate with other parts of the body is by way of tiny exosome vesicles in blood or other fluids. Ranging in size from 40 to 120 nanometers, or about 1000 times smaller in width than a strand of hair, the exosomes are thought to shuttle molecules from parent cancer cells through the body, entering and then re-programming friendly cells to become cancerous. Cancer cells also secrete more exosome bubbles than regular cells.
“Exosomes provide a unique opportunity as a cancer marker,” Dong said.
However, finding the cancer-filled exosomes in blood testing is challenging. They look the same as normal cell exosomes and other extracellular bubbles, and they are at very low levels in the blood in early cancer.
The WSU team for the first time applied a technology that uses an electric field to rapidly isolate, enrich and detect the exosomes taken from a prostate cancer cell line. The technology was able to concentrate and then separate the cancer-cell exosomes from those from normal cells by way of immune-binding. That is, the researchers captured the target exosomes by using an antibody that is specific to a protein marker on the exosome surface. The researchers were also able to separate out and analyze cancer protein markers within the exosomes. The technology was 33 times more sensitive than conventional methods that are used in research labs to detect and analyze exosomes.
“This has the potential to become a technique capable of concentrating samples by orders of magnitude in minutes,” Dong said.
The researchers demonstrated their technology successfully with a test serum. They are now working to improve it using a greater amount of human blood which, with a confusing mix of hormones, lipids, and other elements floating around, can create a challenging environment for successful testing. The researchers are also working to adjust the power requirements of the technology, so that it can be used portably and more easily in a medical setting.
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Cancer blood test
- Commentary: Support Early Detection Technology to Save the Lives of Black Cancer Patients
Rhonda Smith, Executive Director of the California Black Health Network, is advocating for the passage of the Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act to ...
- Tony Hill on overcoming prostate cancer and advocating for early detection
Tony Hill is a former Florida state Senator, a fighter for the working people, an Army veteran, and a devoted Christian, hoping to save souls and li ...
- A blood test to help detect lung cancer? New test offered at 18 locations
Julie Harris had never been tested for lung cancer. A low-dose CT scan, the only recommended screening for adults at risk of developing lung cancer, was not something she'd ever found time to do.
- Exact Sciences blood test for many cancers is going to patients this summer
Meanwhile, a competitor has received federal approval for a stool-based colon cancer screening test to rival Exact Sciences' similar Cologuard.
- Guardant Health preps for FDA advisory panel review of its blood-based colorectal cancer screening test
Guardant Health has its sights set on redefining how people get checked for colorectal cancer, and its blood test for catching stray tumor DNA soon has a date with the FDA. The agency has scheduled an ...
Go deeper with Google Headlines on:
Cancer blood test
[google_news title=”” keyword=”cancer blood test” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
Cancer biomarkers
- Self-assembled Na-doped zinc oxide for the detection of lung cancer biomarker VOCs at low concentrations
Developing high-performance gas sensors for the detection of lung cancer markers at low concentrations is a crucial step towards achieving early lung cancer monitoring through breath tests. Metal ...
- Intense ultrasound extracts genetic info for less invasive cancer biopsies
Ultrasound imaging offers a valuable and noninvasive way to find and monitor cancerous tumors. However, much of the most crucial information about a cancer, such as specific cell types and mutations, ...
- Intense ultrasound extracts genetic info for less invasive cancer biopsies #ASA186
At the University of Alberta, researchers explored how intense ultrasound can release biological indicators of disease from cells. These biomarkers can help identify different types of cancer and ...
- Cancer Biomarkers Market Elevating Engagement Making Focus Groups a Catalyst for Insights
The report’s in-depth market assessment and examination of client and furnish chain dynamics features aid organizations in developing their sales, marketing, and merchandising strategies. Additionally ...
- Massive study identifies new biomarkers for renal cancer subtypes, improving diagnosis and—eventually—treatment
A new study led by University of Michigan Health Rogel Cancer Center researchers identifies novel biomarkers in renal cell carcinomas. The researchers' integrative analysis of comprehensive ...
Go deeper with Google Headlines on:
Cancer biomarkers
[google_news title=”” keyword=”cancer biomarkers” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]